New hope for Hard-to-Treat cancers: PTT-4256 enters human trials

NCT ID NCT06634849

Recruiting now Disease control Sponsor: Pathios Therapeutics Pty Ltd Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 30 times

Summary

This early-stage trial tests a new drug called PTT-4256 in 30 adults with advanced solid tumors that have spread. The main goal is to check safety and find the best dose. Researchers will also look for early signs that the drug shrinks tumors or slows cancer growth.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Austin Health
RECRUITING

Heidelberg, Victoria, 3084, Australia
Blacktown Hospital
RECRUITING

Blacktown, New South Wales, 2148, Australia
Linear Clinical Research
RECRUITING

Nedlands, Western Australia, 6009, Australia
Scientia Clinical Research
RECRUITING

Randwick, New South Wales, 2031, Australia
Southern Oncology Clinical Research Unit (SOCRU)
RECRUITING

Adelaide, South Australia, 5042, Australia

Conditions

Explore the condition pages connected to this study.

ADVANCED SOLID TUMOR